 | • レポートコード：MRC2102QY5669 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のガバペンチン市場について種類別（カプセル、タブレット）、用途別（てんかん、神経因性疼痛、むずむず脚症候群、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ガバペンチン市場の概要 ・世界の主要地域別ガバペンチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のガバペンチン市場規模2015-2026：種類別（カプセル、タブレット） ・世界のガバペンチン市場規模2015-2026：用途別（てんかん、神経因性疼痛、むずむず脚症候群、その他） ・ガバペンチンの米国市場規模2015-2020 ・ガバペンチンのヨーロッパ市場規模2015-2020 ・ガバペンチンの中国市場規模2015-2020 ・ガバペンチンの日本市場規模2015-2020 ・ガバペンチンの東南アジア市場規模2015-2020 ・ガバペンチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ガバペンチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ガバペンチンの市場動向・機会・課題 ・調査の結論 |
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Gabapentin was originally marketed under the brand name Neurontin and since it became generic, it has been marketed under many other brand names. An extended-release formulation of gabapentin for once-daily administration was introduced in 2011 for postherpetic neuralgia under the brand name Gralise.
Gabapentin is used primarily to treat seizures and neuropathic pain. It is also commonly prescribed for many off-label uses, such as treatment of anxiety disorders, insomnia, and bipolar disorder. There are, however, concerns regarding the quality of the trials conducted and evidence for some such uses, especially in the case of its use as a mood stabilizer in bipolar disorder.
In 2018, the global Gabapentin market size was 1430 million US$ and is forecast to 1630 million US in 2025, growing at a CAGR of 1.8% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Gabapentin.
Market Analysis and Insights: Global Gabapentin Market
The global Gabapentin market size is projected to reach US$ 1686.7 million by 2026, from US$ 1515.5 million in 2020, at a CAGR of 1.8% during 2021-2026.
Global Gabapentin Scope and Market Size
The global Gabapentin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gabapentin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Gabapentin market is segmented into
Capsule
Tablet
Segment by Application, the Gabapentin market is segmented into
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
The Gabapentin market is analysed and market size information is provided by regions (countries). Segment by Application, the Gabapentin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gabapentin Market Share Analysis
Gabapentin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gabapentin business, the date to enter into the Gabapentin market, Gabapentin product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
1 Gabapentin Market Overview
1.1 Gabapentin Product Scope
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Sales by Type (2020-2026)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Application
1.3.1 Global Gabapentin Sales Comparison by Application (2020-2026)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Gabapentin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gabapentin Sales Growth Rate (2015-2026)
1.4.2 Global Gabapentin Revenue and Growth Rate (2015-2026)
1.4.3 Global Gabapentin Price Trends (2015-2026)
2 Gabapentin Estimate and Forecast by Region
2.1 Global Gabapentin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gabapentin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gabapentin Sales Market Share by Region (2015-2020)
2.2.2 Global Gabapentin Revenue Market Share by Region (2015-2020)
2.3 Global Gabapentin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gabapentin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gabapentin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gabapentin Estimates and Projections (2015-2026)
2.4.2 Europe Gabapentin Estimates and Projections (2015-2026)
2.4.3 China Gabapentin Estimates and Projections (2015-2026)
2.4.4 Japan Gabapentin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gabapentin Estimates and Projections (2015-2026)
2.4.6 India Gabapentin Estimates and Projections (2015-2026)
3 Global Gabapentin Competition Landscape by Players
3.1 Global Top Gabapentin Players by Sales (2015-2020)
3.2 Global Top Gabapentin Players by Revenue (2015-2020)
3.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2019)
3.4 Global Gabapentin Average Price by Company (2015-2020)
3.5 Manufacturers Gabapentin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gabapentin Players (Opinion Leaders)
4 Global Gabapentin Market Size by Type
4.1 Global Gabapentin Historic Market Review by Type (2015-2020)
4.1.1 Global Gabapentin Sales Market Share by Type (2015-2020)
4.1.2 Global Gabapentin Revenue Market Share by Type (2015-2020)
4.1.3 Global Gabapentin Price by Type (2015-2020)
4.2 Global Gabapentin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gabapentin Sales Forecast by Type (2021-2026)
4.2.2 Global Gabapentin Revenue Forecast by Type (2021-2026)
4.2.3 Global Gabapentin Price Forecast by Type (2021-2026)
5 Global Gabapentin Market Size by Application
5.1 Global Gabapentin Historic Market Review by Application (2015-2020)
5.1.1 Global Gabapentin Sales Market Share by Application (2015-2020)
5.1.2 Global Gabapentin Revenue Market Share by Application (2015-2020)
5.1.3 Global Gabapentin Price by Application (2015-2020)
5.2 Global Gabapentin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gabapentin Sales Forecast by Application (2021-2026)
5.2.2 Global Gabapentin Revenue Forecast by Application (2021-2026)
5.2.3 Global Gabapentin Price Forecast by Application (2021-2026)
6 United States Gabapentin Market Facts & Figures
6.1 United States Gabapentin Sales Market Share by Company (2015-2020)
6.2 United States Gabapentin Sales Market Share by Type (2015-2020)
6.3 United States Gabapentin Sales Market Share by Application (2015-2020)
7 Europe Gabapentin Market Facts & Figures
7.1 Europe Gabapentin Sales Market Share by Company (2015-2020)
7.2 Europe Gabapentin Sales Market Share by Type (2015-2020)
7.3 Europe Gabapentin Sales Market Share by Application (2015-2020)
8 China Gabapentin Market Facts & Figures
8.1 China Gabapentin Sales Market Share by Company (2015-2020)
8.2 China Gabapentin Sales Market Share by Type (2015-2020)
8.3 China Gabapentin Sales Market Share by Application (2015-2020)
9 Japan Gabapentin Market Facts & Figures
9.1 Japan Gabapentin Sales Market Share by Company (3015-3030)
9.2 Japan Gabapentin Sales Market Share by Type (2015-2020)
9.3 Japan Gabapentin Sales Market Share by Application (2015-2020)
10 Southeast Asia Gabapentin Market Facts & Figures
10.1 Southeast Asia Gabapentin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Gabapentin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Gabapentin Sales Market Share by Application (2015-2020)
11 India Gabapentin Market Facts & Figures
11.1 India Gabapentin Sales Market Share by Company (2015-2020)
11.2 India Gabapentin Sales Market Share by Type (2015-2020)
11.3 India Gabapentin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gabapentin Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Gabapentin Products Offered
12.1.5 Pfizer Recent Development
12.2 Assertio Therapeutics
12.2.1 Assertio Therapeutics Corporation Information
12.2.2 Assertio Therapeutics Business Overview
12.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Assertio Therapeutics Gabapentin Products Offered
12.2.5 Assertio Therapeutics Recent Development
12.3 TEVA
12.3.1 TEVA Corporation Information
12.3.2 TEVA Business Overview
12.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 TEVA Gabapentin Products Offered
12.3.5 TEVA Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Gabapentin Products Offered
12.4.5 Mylan Recent Development
12.5 Arbor Pharma
12.5.1 Arbor Pharma Corporation Information
12.5.2 Arbor Pharma Business Overview
12.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Arbor Pharma Gabapentin Products Offered
12.5.5 Arbor Pharma Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Gabapentin Products Offered
12.6.5 Novartis Recent Development
12.7 Apotex
12.7.1 Apotex Corporation Information
12.7.2 Apotex Business Overview
12.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Apotex Gabapentin Products Offered
12.7.5 Apotex Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Business Overview
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sun Pharmaceutical Gabapentin Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Aurobindo Pharma
12.9.1 Aurobindo Pharma Corporation Information
12.9.2 Aurobindo Pharma Business Overview
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aurobindo Pharma Gabapentin Products Offered
12.9.5 Aurobindo Pharma Recent Development
12.10 Intas
12.10.1 Intas Corporation Information
12.10.2 Intas Business Overview
12.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Intas Gabapentin Products Offered
12.10.5 Intas Recent Development
12.11 Amneal
12.11.1 Amneal Corporation Information
12.11.2 Amneal Business Overview
12.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Amneal Gabapentin Products Offered
12.11.5 Amneal Recent Development
12.12 Marksans Pharma
12.12.1 Marksans Pharma Corporation Information
12.12.2 Marksans Pharma Business Overview
12.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Marksans Pharma Gabapentin Products Offered
12.12.5 Marksans Pharma Recent Development
12.13 Glenmark
12.13.1 Glenmark Corporation Information
12.13.2 Glenmark Business Overview
12.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Glenmark Gabapentin Products Offered
12.13.5 Glenmark Recent Development
12.14 Alkem
12.14.1 Alkem Corporation Information
12.14.2 Alkem Business Overview
12.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alkem Gabapentin Products Offered
12.14.5 Alkem Recent Development
12.15 Jiangsu Enhua
12.15.1 Jiangsu Enhua Corporation Information
12.15.2 Jiangsu Enhua Business Overview
12.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Jiangsu Enhua Gabapentin Products Offered
12.15.5 Jiangsu Enhua Recent Development
12.16 Jiangsu Hengrui
12.16.1 Jiangsu Hengrui Corporation Information
12.16.2 Jiangsu Hengrui Business Overview
12.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Jiangsu Hengrui Gabapentin Products Offered
12.16.5 Jiangsu Hengrui Recent Development
12.17 Sailike
12.17.1 Sailike Corporation Information
12.17.2 Sailike Business Overview
12.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Sailike Gabapentin Products Offered
12.17.5 Sailike Recent Development
13 Gabapentin Manufacturing Cost Analysis
13.1 Gabapentin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gabapentin
13.4 Gabapentin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gabapentin Distributors List
14.3 Gabapentin Customers
15 Market Dynamics
15.1 Gabapentin Market Trends
15.2 Gabapentin Opportunities and Drivers
15.3 Gabapentin Market Challenges
15.4 Gabapentin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gabapentin Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Gabapentin Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Gabapentin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Gabapentin Sales (K MT) by Region (2015-2020)
Table 5. Global Gabapentin Sales Market Share by Region (2015-2020)
Table 6. Global Gabapentin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Gabapentin Revenue Share by Region (2015-2020)
Table 8. Global Gabapentin Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Gabapentin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Gabapentin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Gabapentin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Gabapentin (K MT) of Key Companies (2015-2020)
Table 13. Global Gabapentin Sales Share by Company (2015-2020)
Table 14. Global Gabapentin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Gabapentin Revenue Share by Company (2015-2020)
Table 16. Global Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2019)
Table 17. Global Gabapentin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Gabapentin Manufacturing Sites and Area Served
Table 19. Manufacturers Gabapentin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Gabapentin Players
Table 22. Global Gabapentin Sales (K MT) by Type (2015-2020)
Table 23. Global Gabapentin Sales Share by Type (2015-2020)
Table 24. Global Gabapentin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Gabapentin Price (K MT) by Type (2015-2020)
Table 26. Global Gabapentin Sales Share by Type (2021-2026)
Table 27. Global Gabapentin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Gabapentin Revenue Share by Type (2021-2026)
Table 29. Global Gabapentin Price (K MT) by Type (2021-2026)
Table 30. Global Gabapentin Sales (K MT) by Application (2015-2020)
Table 31. Global Gabapentin Sales Share by Application (2015-2020)
Table 32. Global Gabapentin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Gabapentin Price (K MT) by Application (2015-2020)
Table 34. Global Gabapentin Sales (K MT) by Application (2021-2026)
Table 35. Global Gabapentin Sales Share by Application (2021-2026)
Table 36. Global Gabapentin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Gabapentin Revenue Share by Application (2021-2026)
Table 38. Global Gabapentin Price (K MT) by Application (2021-2026)
Table 39. United States Gabapentin Sales (K MT) by Company (2015-2020)
Table 40. United States Gabapentin Sales Market Share by Company (2015-2020)
Table 41. United States Gabapentin Sales (K MT) by Type (2015-2020)
Table 42. United States Gabapentin Sales Market Share by Type (2015-2020)
Table 43. United States Gabapentin Sales (K MT) by Application (2015-2020)
Table 44. United States Gabapentin Sales Market Share by Application (2015-2020)
Table 45. Europe Gabapentin Sales (K MT) by Company (2015-2020)
Table 46. Europe Gabapentin Sales Market Share by Company (2015-2020)
Table 47. Europe Gabapentin Sales (K MT) by Type (2015-2020)
Table 48. Europe Gabapentin Sales Market Share by Type (2015-2020)
Table 49. Europe Gabapentin Sales (K MT) by Application (2015-2020)
Table 50. Europe Gabapentin Sales Market Share by Type (2015-2020)
Table 51. China Gabapentin Sales (K MT) by Company (2015-2020)
Table 52. China Gabapentin Sales Market Share by Company (2015-2020)
Table 53. China Gabapentin Sales (K MT) by Type (2015-2020)
Table 54. China Gabapentin Sales Market Share by Type (2015-2020)
Table 55. China Gabapentin Sales (K MT) by Application (2015-2020)
Table 56. China Gabapentin Sales Market Share by Application (2015-2020)
Table 57. Japan Gabapentin Sales (K MT) by Company (2015-2020)
Table 58. Japan Gabapentin Sales Market Share by Company (2015-2020)
Table 59. Japan Gabapentin Sales (K MT) by Type (2015-2020)
Table 60. Japan Gabapentin Sales Market Share by Type (2015-2020)
Table 61. Japan Gabapentin Sales (K MT) by Application (2015-2020)
Table 62. Japan Gabapentin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Gabapentin Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Gabapentin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Gabapentin Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Gabapentin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Gabapentin Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Gabapentin Sales Market Share by Application (2015-2020)
Table 69. India Gabapentin Sales (K MT) by Company (2015-2020)
Table 70. India Gabapentin Sales Market Share by Company (2015-2020)
Table 71. India Gabapentin Sales (K MT) by Type (2015-2020)
Table 72. India Gabapentin Sales Market Share by Type (2015-2020)
Table 73. India Gabapentin Sales (K MT) by Application (2015-2020)
Table 74. India Gabapentin Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Gabapentin Product
Table 79. Pfizer Recent Development
Table 80. Assertio Therapeutics Corporation Information
Table 81. Assertio Therapeutics Description and Business Overview
Table 82. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Assertio Therapeutics Gabapentin Product
Table 84. Assertio Therapeutics Recent Development
Table 85. TEVA Corporation Information
Table 86. TEVA Description and Business Overview
Table 87. TEVA Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. TEVA Gabapentin Product
Table 89. TEVA Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Mylan Gabapentin Product
Table 94. Mylan Recent Development
Table 95. Arbor Pharma Corporation Information
Table 96. Arbor Pharma Description and Business Overview
Table 97. Arbor Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Arbor Pharma Gabapentin Product
Table 99. Arbor Pharma Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Novartis Gabapentin Product
Table 104. Novartis Recent Development
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Business Overview
Table 107. Apotex Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Apotex Gabapentin Product
Table 109. Apotex Recent Development
Table 110. Sun Pharmaceutical Corporation Information
Table 111. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Sun Pharmaceutical Description and Business Overview
Table 113. Sun Pharmaceutical Gabapentin Product
Table 114. Sun Pharmaceutical Recent Development
Table 115. Aurobindo Pharma Corporation Information
Table 116. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Aurobindo Pharma Description and Business Overview
Table 118. Aurobindo Pharma Gabapentin Product
Table 119. Aurobindo Pharma Recent Development
Table 120. Intas Corporation Information
Table 121. Intas Description and Business Overview
Table 122. Intas Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Intas Gabapentin Product
Table 124. Intas Recent Development
Table 125. Amneal Corporation Information
Table 126. Amneal Description and Business Overview
Table 127. Amneal Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Amneal Gabapentin Product
Table 129. Amneal Recent Development
Table 130. Marksans Pharma Corporation Information
Table 131. Marksans Pharma Description and Business Overview
Table 132. Marksans Pharma Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Marksans Pharma Gabapentin Product
Table 134. Marksans Pharma Recent Development
Table 135. Glenmark Corporation Information
Table 136. Glenmark Description and Business Overview
Table 137. Glenmark Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Glenmark Gabapentin Product
Table 139. Glenmark Recent Development
Table 140. Alkem Corporation Information
Table 141. Alkem Description and Business Overview
Table 142. Alkem Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Alkem Gabapentin Product
Table 144. Alkem Recent Development
Table 145. Jiangsu Enhua Corporation Information
Table 146. Jiangsu Enhua Description and Business Overview
Table 147. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Jiangsu Enhua Gabapentin Product
Table 149. Jiangsu Enhua Recent Development
Table 150. Jiangsu Hengrui Corporation Information
Table 151. Jiangsu Hengrui Description and Business Overview
Table 152. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Jiangsu Hengrui Gabapentin Product
Table 154. Jiangsu Hengrui Recent Development
Table 155. Sailike Corporation Information
Table 156. Sailike Description and Business Overview
Table 157. Sailike Gabapentin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Sailike Gabapentin Product
Table 159. Sailike Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Gabapentin Distributors List
Table 163. Gabapentin Customers List
Table 164. Gabapentin Market Key Trends
Table 165. Gabapentin Key Opportunities and Drivers
Table 166. Gabapentin Market Challenges
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Product Picture
Figure 2. Global Gabapentin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gabapentin Market Share by Application in 2020 & 2026
Figure 6. Epilepsy Examples
Figure 7. Neuropathic Pain Examples
Figure 8. Restless Legs Syndrome Examples
Figure 9. Others Examples
Figure 10. Global Gabapentin Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Gabapentin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Gabapentin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Gabapentin Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Gabapentin Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Gabapentin Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Gabapentin Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Gabapentin Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Gabapentin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Gabapentin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Gabapentin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Gabapentin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Gabapentin Players Market Share by Revenue in Gabapentin 2015 & 2019
Figure 28. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Gabapentin Revenue Share by Type (2015-2020)
Figure 30. Global Gabapentin Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Gabapentin Revenue Share by Application (2015-2020)
Figure 32. Global Gabapentin Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Gabapentin Sales Market Share by Type in 2019
Figure 34. United States Gabapentin Sales Market Share by Type in 2019
Figure 35. Europe Gabapentin Sales Market Share by Company in 2019
Figure 36. Europe Gabapentin Sales Market Share by Type in 2019
Figure 37. Europe Gabapentin Sales Market Share by Application in 2019
Figure 38. China Gabapentin Sales Market Share by Company in 2019
Figure 39. China Gabapentin Sales Market Share by Type in 2019
Figure 40. China Gabapentin Sales Market Share by Application in 2019
Figure 41. Japan Gabapentin Sales Market Share by Company in 2019
Figure 42. Japan Gabapentin Sales Market Share by Type in 2019
Figure 43. Japan Gabapentin Sales Market Share by Application in 2019
Figure 44. Southeast Asia Gabapentin Sales Market Share by Company in 2019
Figure 45. Southeast Asia Gabapentin Sales Market Share by Type in 2019
Figure 46. Southeast Asia Gabapentin Sales Market Share by Application in 2019
Figure 47. India Gabapentin Sales Market Share by Company in 2019
Figure 48. India Gabapentin Sales Market Share by Type in 2019
Figure 49. India Gabapentin Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Gabapentin
Figure 52. Manufacturing Process Analysis of Gabapentin
Figure 53. Gabapentin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
月経前症候群薬の世界市場レポート2020 Market Analysis and Insights: Global Premenstrual Syndrome Medicine Market The global Premenstrual Syndrome Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Premenstrual Syndrome Medicine Scope and Market Size T…- 疼痛管理薬・デバイスの世界市場レポート2020 Market Analysis and Insights: Global Pain Management Drugs & Devices Market The global Pain Management Drugs & Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pain Management Drugs & Devices Scope and Market Siz…
- 過敏性腸症候群（IBS）の世界市場レポート2020 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…
- 下痢同伴過敏性腸症候群（IBS-D）治療薬の世界市場レポート2020 Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief. Market Analysis and Insights…
- 便秘薬による過敏性腸症候群の世界市場レポート2020 The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely. Market Analysis…